Methods for Extracellular Vesicle Detection and Analysis

Introduction

Extracellular vesicles (EVs) — a broad class encompassing exosomes, microvesicles, and apoptotic bodies — have emerged as pivotal mediators of intercellular communication. Released by virtually all cell types, EVs carry a complex cargo of proteins, nucleic acids, and lipids that reflect the physiological or pathological state of their parent cell. This has positioned EVs at the forefront of biomarker discovery, liquid biopsy development, and therapeutic delivery research.

However, the nanoscale dimensions of EVs (typically 30–1000 nm), their inherent heterogeneity, and the complexity of biological fluids in which they reside make rigorous detection and characterisation exceptionally challenging. Choosing the right analytical method — or combination of methods — is critical to generating reproducible, biologically meaningful data.

This article provides a structured overview of the principal methods used for EV detection and analysis, evaluating their strengths, limitations, and optimal use cases. Whether you are isolating EVs from plasma, cell-conditioned media, or urine, understanding these techniques is essential to robust experimental design and translatable results.

1. Nanoparticle Tracking Analysis (NTA)

Nanoparticle Tracking Analysis is among the most widely adopted methods for EV characterisation. NTA instruments — such as those from NanoSight (Malvern Panalytical) — illuminate vesicles in solution using a laser, and a camera tracks the Brownian motion of individual particles. By applying the Stokes-Einstein equation, the software converts particle diffusion coefficients into hydrodynamic diameter distributions and provides a concentration estimate (particles/mL).

Strengths

• Real-time size distribution (typically 50–1000 nm range)
• Particle concentration quantification
• Relatively straightforward sample preparation
• Fluorescence NTA modes allow protein-labelled EV sub-population analysis

Limitations

• Lower resolution at the extremes of the size range (<70 nm)
• Sensitive to sample dilution, viscosity, and ambient vibration
• Cannot distinguish EVs from protein aggregates or lipoproteins without additional labelling

NTA is recommended as a primary sizing and quantification tool and is required by the Minimal Information for Studies of Extracellular Vesicles (MISEV) guidelines [1].

2. Transmission Electron Microscopy (TEM)

Transmission Electron Microscopy provides direct visualisation of EV morphology at nanometre resolution. Negative staining with uranyl acetate or phosphotungstic acid allows the characteristic cup-shaped or spherical morphology of EVs to be resolved. Cryo-TEM, which preserves vesicles in a vitrified hydrated state, offers superior morphological fidelity by avoiding dehydration-induced artefacts.

Strengths

• Direct morphological evidence — gold standard for confirming vesicular structure
• Cryo-TEM enables near-native state imaging
• Immunogold labelling identifies surface or luminal markers at ultrastructural resolution

Limitations

• Low throughput — statistical representation of the population requires imaging hundreds of vesicles
• Sample preparation can introduce artefacts (dehydration, membrane distortion in conventional TEM)
• Specialised equipment and expertise required

TEM is indispensable for morphological validation but should be complemented by ensemble methods for population-level quantitative data.

3. Dynamic Light Scattering (DLS)

Dynamic Light Scattering measures the time-dependent fluctuations in scattered laser light caused by Brownian motion of particles in suspension. From the autocorrelation function, hydrodynamic radius and polydispersity index (PDI) are derived.

Strengths

• Rapid measurement (minutes per sample)
• Non-destructive and requires minimal sample volume
• Widely available instrumentation

Limitations

• Ensemble measurement biased towards larger particles — small vesicle populations can be masked
• Low resolution for polydisperse EV preparations; poor discrimination of sub-populations
• Requires high sample purity — protein contamination distorts results

DLS is best suited for assessing the homogeneity of purified EV preparations rather than characterising complex biological samples.

4. Flow Cytometry

Conventional flow cytometry (cFC) has historically struggled with EV detection due to the diffraction-limited resolution of most instruments (typically >300 nm). Advances in high-sensitivity flow cytometry (HSFCM) and dedicated nano-flow cytometry platforms — such as the Apogee A60-Micro, Beckman Coulter CytoFLEX, and NovaBright instruments — have dramatically lowered detection thresholds, enabling single-vesicle resolution for EVs as small as 80–100 nm.

Strengths

• High-throughput single-vesicle analysis
• Multiplexed surface marker phenotyping using fluorochrome-conjugated antibodies
• Simultaneous size estimation via side-scatter calibration with silica or polystyrene beads
• Rare EV sub-population identification (e.g., tumour-derived EVs in plasma)

Limitations

• Swarm detection artefacts at high concentrations — requires careful sample dilution
• Background from instrument noise and protein aggregates
• Standardisation across instruments remains a challenge for the field

The International Society for Extracellular Vesicles (ISEV) has published specific recommendations on EV flow cytometry, and the EV-TRACK database supports transparent reporting of flow cytometry EV experiments [2].

5. Western Blotting and Protein Analysis

Western blotting remains a cornerstone technique for confirming the proteomic identity of EV preparations. MISEV guidelines specify a panel of positive (tetraspanins CD9, CD63, CD81; heat shock proteins HSP70/HSP90; flotillin-1; TSG101) and negative (calnexin, GM130, Argonaute proteins) markers to validate EV identity and assess contamination [1].

Strengths

• Widely accessible and well-established methodology
• Identifies canonical EV markers and contaminants
• Semi-quantitative comparison across sample types

Limitations

• Requires relatively large amounts of starting material
• Antibody specificity is critical — cross-reactivity confounds interpretation
• Not suitable for single-vesicle resolution or size-based analysis

Dot blot and ELISA-based approaches offer higher throughput alternatives for EV protein quantification and are increasingly used for clinical sample screening.

6. Tunable Resistive Pulse Sensing (TRPS)

Tunable Resistive Pulse Sensing (e.g., qNano, Izon Science) detects individual vesicles as they pass through a nanopore membrane immersed in electrolyte. Each vesicle generates a transient ionic current blockade, from which particle size and concentration are derived.

Strengths

• Single-particle resolution with high sensitivity down to ~50 nm
• Simultaneous size and concentration measurement
• Zeta potential measurement available on some platforms

Limitations

• Nanopore membrane clogging with complex biological samples
• Throughput lower than NTA for large datasets
• Calibration with reference particles is essential for accuracy

TRPS is particularly useful when high-resolution single-particle size distributions are required, and complements NTA well in orthogonal characterisation strategies.

7. Single-Vesicle Fluorescence Techniques

A rapidly expanding category of EV analysis leverages single-molecule and single-vesicle fluorescence microscopy. Techniques including total internal reflection fluorescence (TIRF) microscopy, single-particle tracking (SPT), and super-resolution approaches (STED, STORM, PALM) enable simultaneous characterisation of EV size, surface markers, and cargo loading at the individual vesicle level.

The ExoView platform (NanoView Biosciences) exemplifies a chip-based single-vesicle analysis format: EVs are captured on antibody-coated chips and co-stained with fluorescently labelled antibodies, allowing size, count, and tetraspanin co-expression to be profiled simultaneously.

Strengths

• Single-vesicle resolution — reveals population heterogeneity invisible to ensemble methods
• Multiplexed phenotyping of captured vesicles
• Low sample volume requirements

Limitations

• Capture-based methods may introduce selection bias
• Super-resolution approaches require specialist equipment and analysis pipelines
• Limited standardisation across platforms

8. Omics-Based Approaches

Beyond physical characterisation, the molecular cargo of EVs provides a rich analytical dimension. Proteomics (LC-MS/MS), transcriptomics (small RNA-seq, long RNA-seq), lipidomics, and metabolomics have all been applied to EV research, collectively uncovering the complex molecular landscape of vesicle sub-populations.

Databases such as Vesiclepedia and ExoCarta catalogue thousands of proteins and RNA species identified across EV studies, providing reference frameworks for biomarker discovery [3,4]. Single-vesicle omics approaches — including nanodroplet proteomics and proximity ligation assays — are beginning to resolve the molecular heterogeneity of individual EVs.

Key considerations for EV omics:

• Isolation method critically impacts downstream omics profiles — differential ultracentrifugation, size exclusion chromatography (SEC), and density gradient separation yield distinct EV populations
• Contamination with non-EV proteins (albumin, lipoproteins) must be rigorously controlled
• Data normalisation strategies (per particle count, per protein mass, per EV surface area) significantly affect biological interpretation

9. Choosing the Right Method: A Practical Framework

Given the diversity of available techniques, method selection should be guided by the biological question, sample type, EV sub-population of interest, and available resources. The following framework, aligned with MISEV 2023 recommendations, provides a starting point:

Minimal characterisation (all EV studies should include):

• Size distribution: NTA or DLS
• Particle concentration: NTA or TRPS
• Morphology: TEM (at least representative images)
• Protein markers: Western blot or dot blot for positive and negative markers

Extended characterisation (for mechanistic and biomarker studies):

• Single-vesicle phenotyping: High-sensitivity flow cytometry or ExoView
• Molecular cargo: Proteomics, RNA-seq
• Sub-population analysis: Density gradients combined with NTA/flow cytometry

Orthogonal use of two or more sizing techniques (e.g., NTA + TRPS, or DLS + TEM) is strongly recommended to cross-validate measurements and ensure robustness of reported EV characteristics.

10. Spotlight: The LuminEV Kit — Multiplexed EV Surface Protein Analysis Without Isolation

One of the most significant practical barriers in EV research has been the requirement for prior EV isolation — a process that is time-consuming, technically demanding, and prone to introducing bias through differential recovery of EV sub-populations. The LuminEV Kit (LuminEV.co) directly addresses this bottleneck by enabling multiplexed analysis of EV surface proteins in plasma and cell culture media without any upstream isolation step.

How It Works

The LuminEV Kit is an advanced immunoassay-based platform that captures and profiles EV surface proteins directly from unprocessed biological samples. Designed for a 96-well format, the assay simultaneously detects three canonical EV tetraspanin markers — CD9, CD63, and CD81 — enabling both quantification and colocalization analysis of EV sub-populations expressing different surface protein combinations. The entire workflow requires fewer than five hours of hands-on time, making it well-suited to both discovery research and high-throughput screening applications.

Key Capabilities

• Multiplexed surface protein analysis: simultaneous detection of CD9, CD63, and CD81 on the same vesicle population
• No EV isolation required: compatible with raw plasma and cell culture media, eliminating workflow bias and sample loss
• Colocalization analysis: identifies EVs co-expressing multiple surface markers, revealing sub-population heterogeneity
• High sensitivity and specificity: detects low-abundance EV surface proteins from limited sample volumes
• Excellent precision: coefficient of variation (CV) below 15% with a wide dynamic range
• Scalable throughput: 96-well plate format supports large cohort studies and compound screening

Applications

The LuminEV Kit has been validated across a range of research contexts where conventional EV characterisation methods face significant limitations:

• Biomarker discovery: profiling EV surface protein signatures in plasma across patient cohorts, with built-in normalisation parameters
• EV secretion screening: identifying compounds or conditions that modulate EV release in cell-based assays
• Therapeutic EV quality control: standardised batch-to-batch assessment of surface protein composition for EV-based therapeutics
• Basic EV biology: characterising EV sub-populations and their surface marker profiles across cell types and conditions
• Large-scale epidemiological studies: enabling EV analysis at population scale without the resource demands of isolation-dependent workflows

Scientific Validation

The LuminEV platform is underpinned by a peer-reviewed publication in the Journal of Extracellular Vesicles, validating its performance for multiplexed immunoassay-based detection of surface-exposed proteins in plasma EVs. This positions the LuminEV Kit among a small number of commercially available EV analysis tools with published, independent performance data.

Where LuminEV Fits in the EV Analysis Landscape

Within the framework described throughout this article, the LuminEV Kit occupies a distinct and complementary role. While NTA, TEM, and DLS characterise the physical properties of the total EV population, and flow cytometry enables single-vesicle phenotyping, the LuminEV Kit provides a uniquely accessible route to surface protein-level characterisation — without the technical overhead of ultracentrifugation or density gradient purification. For researchers conducting large clinical studies, screening compound libraries, or working with precious low-volume samples, the LuminEV Kit offers a practical and rigorously validated solution.

The LuminEV Kit is available in three configurations (1 x 96-well plate, 5 x 96-well plates, 20 x 96-well plates) to support projects of varying scale. Full assay documentation is available at luminev.co/assay-manual.

Conclusion

The field of extracellular vesicle research has matured considerably, yet the analytical challenges posed by EV heterogeneity, nanoscale dimensions, and complex biological matrices remain formidable. No single technique provides a complete picture; rigorous EV science demands a multi-modal characterisation strategy guided by community-developed reporting standards such as MISEV and EV-TRACK.

At LuminEV.co, we are committed to supporting researchers with tools, reagents, and resources that advance the reliable detection and functional analysis of extracellular vesicles. As detection technologies continue to evolve — from nano-flow cytometry to single-vesicle multi-omics — the capacity to resolve the full complexity of the EV landscape is rapidly approaching.

References

[1] Théry C, et al. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 7(1):1535750.

[2] Van Deun J, et al. (2017). EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nature Methods, 14(3):228–232.

[3] Pathan M, et al. (2019). Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Research, 47(D1):D516–D519.

[4] Keerthikumar S, et al. (2016). ExoCarta: A Web-Based Compendium of Exosomal Cargo. Journal of Molecular Biology, 428(4):688–692.

[5] Welsh JA, et al. (2024). Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles, 13(1):e12404.

[6] Nolan JP & Duggan E. (2018). Analysis of Individual Extracellular Vesicles by Flow Cytometry. Methods in Molecular Biology, 1678:79–92.

[7] van der Pol E, et al. (2012). Classification, functions, and clinical relevance of extracellular vesicles. Pharmacological Reviews, 64(3):676–705.

[8] Dragovic RA, et al. (2011). Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine, 7(6):780–788.

[9] Sódar BW, et al. (2024). A novel multiplexed immunoassay for surface-exposed proteins in plasma extracellular vesicles. Journal of Extracellular Vesicles, 13:e70007. Available at: https://isevjournals.onlinelibrary.wiley.com/doi/10.1002/jev2.70007

© 2025 LuminEV.co  |  www.luminev.co  |  All rights reserved